Artivion Inc.

NYSE: AORT · Real-Time Price · USD
42.73
-0.08 (-0.19%)
At close: Aug 18, 2025, 3:59 PM
42.85
0.28%
Pre-market: Aug 19, 2025, 04:09 AM EDT

Artivion Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2014
Aortic Stent Grafts Revenue 123.08M 107.47M 92.75M 57.36M 48.05M 78.98M 75.45M 37.04M 34.23M 62.76M
Aortic Stent Grafts Revenue Growth +14.53% +15.87% +61.69% +19.37% -39.15% +4.68% +103.69% +8.21% -45.45% n/a
On X Revenue 83.98M 74.53M 63.9M 8.13M 73.93M 50.1M 44.83M n/a n/a n/a
On X Revenue Growth +12.69% +16.62% +685.74% -89.00% +47.57% +11.74% n/a n/a n/a n/a
Other Products Revenue 9.27M 11.17M 8.32M 70.71M n/a n/a n/a n/a n/a n/a
Other Products Revenue Growth -17.03% +34.31% -88.24% n/a n/a n/a n/a n/a n/a n/a
Surgical Sealants Revenue 73.9M 92.82M 83.44M 77.24M n/a n/a n/a n/a n/a n/a
Surgical Sealants Revenue Growth -20.38% +11.25% +8.02% n/a n/a n/a n/a n/a n/a n/a
Preservation Services Revenue 98.31M 68.02M 65.38M 85.39M n/a n/a n/a n/a n/a n/a
Preservation Services Revenue Growth +44.54% +4.03% -23.43% n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024
Asia Pacific Segment Revenue 37.2M
Asia Pacific Segment Revenue Growth n/a
Europe, The Middle East, And Africa Segments Revenue 131.52M
Europe, The Middle East, And Africa Segments Revenue Growth n/a
Latin America Segment Revenue 21.88M
Latin America Segment Revenue Growth n/a
North America Segment Revenue 197.94M
North America Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 57.66M 54.7M 51.43M 50.02M 47.52M 48.14M 50.28M 51.09M 57.24M 45.54M 38.45M 41.05M 38.98M 38.95M 51.25M 39.05M 40.83M 38.64M 36.1M 33.74M 32.29M 39M 37.61M 34.26M 34.62M 36.52M 42.53M 32.87M 34.73M 37.35M 30.2M 24.76M 23.39M 22.87M 29.25M 20.59M 22.44M 26.27M 19.14M 17.49M 19.33M 18.97M
Selling, General, and Administrative Revenue Growth +5.41% +6.37% +2.82% +5.25% -1.28% -4.26% -1.60% -10.74% +25.68% +18.44% -6.33% +5.30% +0.07% -23.99% +31.24% -4.35% +5.67% +7.02% +6.99% +4.51% -17.21% +3.70% +9.78% -1.05% -5.19% -14.13% +29.38% -5.34% -7.02% +23.69% +21.97% +5.84% +2.26% -21.80% +42.03% -8.22% -14.61% +37.28% +9.40% -9.48% +1.89% n/a
Research and Development Revenue 7.06M 6.73M 7.4M 6.61M 7.5M 6.95M 7.64M 6.42M 7.42M 7.22M 8.3M 11.8M 8.65M 10.13M 9.46M 9.97M 8.36M 7.75M 6.57M 5.75M 5.52M 6.36M 5.31M 6.26M 5.84M 5.55M 6.78M 5.22M 5.72M 5.37M 6.36M 4.28M 4.73M 4.09M 3.84M 3.71M 3.28M 2.61M 2.54M 2.96M 2.68M 2.25M
Research and Development Revenue Growth +4.98% -9.13% +12.10% -11.90% +7.93% -9.14% +19.06% -13.44% +2.70% -13.02% -29.62% +36.44% -14.61% +7.06% -5.13% +19.28% +7.82% +17.95% +14.23% +4.22% -13.12% +19.65% -15.13% +7.16% +5.28% -18.22% +29.84% -8.64% +6.50% -15.61% +48.77% -9.54% +15.51% +6.48% +3.50% +13.27% +25.68% +2.72% -14.19% +10.28% +19.18% n/a